ZAI LAB LIMITED Interest Income, Deposits with Financial Institutions
ZAI LAB LIMITED (ZLAB) reported Interest Income, Deposits with Financial Institutions of $799.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeDepositsWithFinancialInstitutions · last filed 2022-03-01
- ZAI LAB LIMITED interest income, deposits with financial institutions for the quarter ending 2019-12-31 was $2.88M, a 54.81% increase year-over-year.
- ZAI LAB LIMITED interest income, deposits with financial institutions for the quarter ending 2019-09-30 was $1.59M.
- ZAI LAB LIMITED interest income, deposits with financial institutions for the quarter ending 2018-12-31 was $1.86M.
- ZAI LAB LIMITED interest income, deposits with financial institutions for fiscal 2021 was $799.00K, a 83.56% decline from fiscal 2020.
- ZAI LAB LIMITED interest income, deposits with financial institutions for fiscal 2020 was $4.86M, a 37.52% decline from fiscal 2019.
- ZAI LAB LIMITED interest income, deposits with financial institutions for fiscal 2019 was $7.78M, a 229.72% increase from fiscal 2018.
- ZAI LAB LIMITED interest income, deposits with financial institutions for fiscal 2018 was $2.36M.
| Period end | Interest Income, Deposits with Financial Institutions 3 month | Interest Income, Deposits with Financial Institutions 6 month | Interest Income, Deposits with Financial Institutions 9 month | Interest Income, Deposits with Financial Institutions 12 month | Interest Income, Deposits with Financial Institutions 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $799.00K 10-K · filed 2022-03-01 | ||||
| 2020-12-31 | $4.86M 10-K · filed 2022-03-01 | ||||
| 2020-06-30 | $2.51M 6-K · filed 2020-09-11 | ||||
| 2019-12-31 | $2.88M derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | $4.47M derived: sum of 2 quarters · filed 2022-03-01 | $7.78M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $1.59M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $4.90M 6-K · filed 2020-01-21 | |||
| 2019-06-30 | $3.31M 6-K · filed 2020-09-11 | ||||
| 2018-12-31 | $1.86M derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | $2.36M 10-K · filed 2021-03-01 | $2.40M 20-F · filed 2019-03-29 | ||
| 2018-09-30 | $500.00K 6-K · filed 2020-01-21 | ||||
| 2017-12-31 | $0.00 20-F · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |